2-Cys peroxiredoxins: Emerging hubs determining redox dependency of mammalian signaling networks

International Journal of Cell Biology

Volumn , Issue , 2014, Pages

  Park, Jinah ^a   Lee, Sunmi ^b   Lee, Sanghyuk ^b   Kang, Sang Won ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYS PEROXIREDOXIN; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PEROXIDASE; PEROXIREDOXIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ACETYLATION; APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; LIPID PEROXIDATION; MAMMAL CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84896823538     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2014/715867     Document Type: Review

References (88)

1. Kang S. W., Chae H. Z., Seo M. S., Kim K., Baines I. C., Rhee S. G., Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generatedin response to growth factors and tumor necrosis factor- α The Journal of Biological Chemistry 1998 273 11 6297 6302 2-s2.0-0141746553 10.1074/jbc.273.11.6297
2. Chae H. Z., Chung S. J., Rhee S. G., Thioredoxin-dependent peroxide reductase from yeast. The Journal of Biological Chemistry 1994 269 44 27670 27678 2-s2.0-0028072911
3. Kang S. W., Rhee S. G., Chang T.-S., Jeong W., Choi M. H., 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends in Molecular Medicine 2005 11 12 571 578 2-s2.0-28244495868 10.1016/j.molmed.2005.10.006
4. Seo M. S., Kang S. W., Kim K., Baines I. C., Lee T. H., Rhee S. G., Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. The Journal of Biological Chemistry 2000 275 27 20346 20354 2-s2.0-0001015125 10.1074/jbc.M001943200
5. Zito E., Melo E. P., Yang Y., Wahlander Å., Neubert T. A., Ron D., Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin. Molecular Cell 2010 40 5 787 797 2-s2.0-78649918283 10.1016/j.molcel.2010.11.010
6. Tavender T. J., Springate J. J., Bulleid N. J., Recycling of peroxiredoxin IV provides a novel pathway for disulphide formation in the endoplasmic reticulum. The EMBO Journal 2010 29 24 4185 4197 2-s2.0-78650270477 10.1038/emboj.2010.273
7. Biteau B., Labarre J., Toledano M. B., ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 2003 425 6961 980 984 2-s2.0-0242416188 10.1038/nature02075
8. Yang K.-S., Kang S. W., Woo H. A., Hwang S. C., Chae H. Z., Kim K., Rhee S. G., Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. The Journal of Biological Chemistry 2002 277 41 38029 38036 2-s2.0-0037064080 10.1074/jbc.M206626200
9. Wood Z. A., Poole L. B., Karplus P. A., Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 2003 300 5619 650 653 2-s2.0-0242668686 10.1126/science.1080405
10. Jang H. H., Lee K. O., Chi Y. H., Jung B. G., Park S. K., Park J. H., Lee J. R., Lee S. S., Moon J. C., Yun J. W., Choi Y. O., Kim W. Y., Kang J. S., Cheong G.-W., Yun D.-J., Rhee S. G., Cho M. J., Lee S. Y., Two enzymes in one: two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 2004 117 5 625 635 2-s2.0-2542464938 10.1016/j.cell.2004.05.002
11. Day A. M., Brown J. D., Taylor S. R., Rand J. D., Morgan B. A., Veal E. A., Inactivation of a peroxiredoxin by hydrogen peroxide is critical for thioredoxin-mediated repair of oxidized proteins and cell survival. Molecular Cell 2012 45 3 398 408 2-s2.0-84856808054 10.1016/j.molcel.2011.11.027
12. O'Neill J. S., Reddy A. B., Circadian clocks in human red blood cells. Nature 2011 469 7331 498 503 2-s2.0-79251566511 10.1038/nature09702
13. Edgar R. S., Green E. W., Zhao Y., van Ooijen G., Olmedo M., Qin X., Xu Y., Pan M., Valekunja U. K., Feeney K. A., Maywood E. S., Hastings M. H., Baliga N. S., Merrow M., Millar A. J., Johnson C. H., Kyriacou C. P., O'Neill J. S., Reddy A. B., Peroxiredoxins are conserved markers of circadian rhythms. Nature 2012 485 7399 459 464 10.1038/nature11088
14. Fomenko D. E., Koc A., Agisheva N., Jacobsen M., Kaya A., Malinouski M., Rutherford J. C., Siu K.-L., Jin D.-Y., Winge D. R., Gladyshev V. N., Thiol peroxidases mediate specific genome-wide regulation of gene expression in response to hydrogen peroxide. Proceedings of the National Academy of Sciences of the United States of America 2011 108 7 2729 2734 2-s2.0-79952582563 10.1073/pnas.1010721108
15. Barford D., Flint A. J., Tonks N. K., Crystal structure of human protein tyrosine phosphatase 1B. Science 1994 263 5152 1397 1404 2-s2.0-0028231388 10.1126/science.8128219
16. Zhang Z.-Y., Dixon J. E., Active site labeling of the yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402. Biochemistry 1993 32 36 9340 9345 2-s2.0-0027383705 10.1021/bi00087a012
17. Denu J. M., Tanner K. G., Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 1998 37 16 5633 5642 2-s2.0-0032554611 10.1021/bi973035t
18. 2 and vanadate in vitro. Biochemical and Biophysical Research Communications 1992 188 2 773 779 2-s2.0-0026452478 10.1016/0006-291X(92)91123-8
19. Bae Y. S., Kang S. W., Seo M. S., Baines I. C., Tckle E., Chock P. B., Rhee S. G., Epidermal growth factor (EGF)-induced generation of hydrogen peroxide: role in EGF receptor-mediated tyrosine phosphorylation. The Journal of Biological Chemistry 1997 272 1 217 221 2-s2.0-15144343374 10.1074/jbc.272.1. 217
20. 2 for platelet-derived growth factor signal transduction. Science 1995 270 5234 296 299 2-s2.0-0028973482 10.1126/science.270.5234.296
21. Chiarugi P., Cirri P., Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends in Biochemical Sciences 2003 28 9 509 514 2-s2.0-0642276003 10.1016/S0968-0004(03)00174-9
22. Rhee S. G., Bae Y. S., Lee S. R., Kwon J., Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Science's STKE 2000 2000 53 pe1 2-s2.0-0034633602 10.1126/stke.2000.53.pe1
23. Jeon K.-I., Byun M.-S., Jue D.-M., Gold compound auranofin inhibits I B kinase (IKK) by modifying Cys-179 of IKK β subunit. Experimental and Molecular Medicine 2003 35 2 61 66 2-s2.0-0038147060 10.1038/emm.2003.9
24. Korn S. H., Wouters E. F. M., Vos N., Janssen-Heininger Y. M. W., Cytokine-induced activation of nuclear factor- B is inhibited by hydrogen peroxide through oxidative inactivation of I B kinase. The Journal of Biological Chemistry 2001 276 38 35693 35700 2-s2.0-0035929670 10.1074/jbc.M104321200
25. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M. G., Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I B kinase. Nature 2000 403 6765 103 108 2-s2.0-0034610759 10.1038/47520
26. Yoo S. K., Starnes T. W., Deng Q., Huttenlocher A., Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 2011 480 7375 109 112 2-s2.0-82555168190 10.1038/nature10632
27. Guo Z., Kozlov S., Lavin M. F., Person M. D., Paull T. T., ATM activation by oxidative stress. Science 2010 330 6003 517 521 2-s2.0-77958191599 10.1126/science.1192912
28. Cao J., Schulte J., Knight A., Leslie N. R., Zagozdzon A., Bronson R., Manevich Y., Beeson C., Neumann C. A., Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. The EMBO Journal 2009 28 10 1505 1517 2-s2.0-67349147914 10.1038/emboj.2009.101
29. Kang S. W., Chang T.-S., Lee T.-H., Kim E. S., Yu D.-Y., Rhee S. G., Cytosolic peroxiredoxin attenuates the activation of JNK and p38 but potentiates that of Erk in HeLa cells stimulated with tumor necrosis factor- α The Journal of Biological Chemistry 2004 279 4 2535 2543 2-s2.0-1642576090 10.1074/jbc.M307698200
30. Choi M. H., Lee I. K., Kim G. W., Kim B. U., Han Y.-H., Yu D.-Y., Park H. S., Kim K. Y., Lee J. S., Choi C., Bae Y. S., Lee B. I., Rhee S. G., Kang S. W., Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 2005 435 7040 347 353 2-s2.0-19644394554 10.1038/nature03587
31. Kang D. H., Lee D. J., Lee K. W., Park Y. S., Lee J. Y., Lee S.-H., Koh Y. J., Koh G.-Y., Choi C., Yu D.-Y., Kim J., Kang S. W., Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Molecular Cell 2011 44 4 545 558 2-s2.0-81355150904 10.1016/j.molcel.2011.08.040
32. Chang T.-S., Jeong W., Choi S. Y., Yu S., Kang S. W., Rhee S. G., Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation. The Journal of Biological Chemistry 2002 277 28 25370 25376 2-s2.0-0037067763 10.1074/jbc.M110432200
33. Rawat S. J., Creasy C. L., Peterson J. R., Chernoff J., The tumor suppressor MST1 promotes changes in the cellular redox state by phosphorylation and inactivation of peroxiredoxin-1 protein. The Journal of Biological Chemistry 2013 288 12 8762 8771 10.1074/jbc.M112.414524
34. Morinaka A., Funato Y., Uesugi K., Miki H., Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis. Oncogene 2011 30 40 4208 4218 2-s2.0-80053614220 10.1038/onc.2011.139
35. Zykova T. A., Zhu F., Vakorina T. I., Zhang J., Higgins L. A., Urusova D. V., Bode A. M., Dong Z., T-LAK cell-originated protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 prevents UVB-induced apoptosis in RPMI7951 melanoma cells through the regulation of Prx1 peroxidase activity. The Journal of Biological Chemistry 2010 285 38 29138 29146 2-s2.0-77956541126 10.1074/jbc.M110.135905
36. Lee K. W., Lee D. J., Lee J. Y., Kang D. H., Kwon J., Kang S. W., Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair. The Journal of Biological Chemistry 2011 286 10 8394 8404 2-s2.0-79953158615 10.1074/jbc.M110.179416
37. Qu D., Rashidian J., Mount M. P., Aleyasin H., Parsanejad M., Lira A., Haque E., Zhang Y., Callaghan S., Daigle M., Rousseaux M. W. C., Slack R. S., Albert P. R., Vincent I., Woulfe J. M., Park D. S., Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 2007 55 1 37 52 2-s2.0-34250897267 10.1016/j.neuron.2007.05.033
38. Angeles D. C., Gan B.-H., Onstead L., Zhao Y., Lim K.-L., Dachsel J., Melrose H., Farrer M., Wszolek Z. K., Dickson D. W., Tan E.-K., Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Human Mutation 2011 32 12 1390 1397 2-s2.0-81255208412 10.1002/humu.21582
39. 2 accumulation for cell signaling. Cell 2010 140 4 517 528 2-s2.0-76749102420 10.1016/j.cell.2010.01.009
40. Woo H. A., Jeong W., Chang T.-S., Kwang J. P., Sung J. P., Jeong S. Y., Sue G. R., Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-Cys peroxiredoxins. The Journal of Biological Chemistry 2005 280 5 3125 3128 2-s2.0-13544272571 10.1074/jbc.C400496200
41. Woo H. A., Chae H. Z., Hwang S. C., Yang K.-S., Kang S. W., Kim K., Rhee S. G., Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 2003 300 5619 653 656 2-s2.0-0242668688 10.1126/science.1080273
42. Norris K. L., Lee J.-Y., Yao T.-P., Acetylation goes global: the emergence of acetylation biology. Science Signaling 2009 2 97 pe76 2-s2.0-77449116892 10.1126/scisignal.297pe76
43. Jenuwein T., Allis C. D., Translating the histone code. Science 2001 293 5532 1074 1080 2-s2.0-0035839136 10.1126/science.1063127
44. Schwer B., North B. J., Frye R. A., Ott M., Verdin E., The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. The Journal of Cell Biology 2002 158 4 647 657 2-s2.0-0037135972 10.1083/jcb.200205057
45. Onyango P., Celic I., McCaffery J. M., Boeke J. D., Feinberg A. P., SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proceedings of the National Academy of Sciences of the United States of America 2002 99 21 13653 13658 2-s2.0-0037108799 10.1073/pnas. 222538099
46. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.-F., Yao T.-P., HDAC6 is a microtubule-associated deacetylase. Nature 2002 417 6887 455 458 2-s2.0-0037161744 10.1038/417455a
47. Ito K., Hanazawa T., Tomita K., Barnes P. J., Adcock I. M., Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochemical and Biophysical Research Communications 2004 315 1 240 245 2-s2.0-0842308109 10.1016/j.bbrc.2004.01.046
48. Ago T., Liu T., Zhai P., Chen W., Li H., Molkentin J. D., Vatner S. F., Sadoshima J., A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 2008 133 6 978 993 2-s2.0-44649184557 10.1016/j.cell.2008.04.041
49. Zee R. S., Yoo C. B., Pimentel D. R., Perlman D. H., Burgoyne J. R., Hou X., McComb M. E., Costello C. E., Cohen R. A., Bachschmid M. M., Redox regulation of sirtuin-1 by S-glutathiolation. Antioxidants and Redox Signaling 2010 13 7 1023 1032 2-s2.0-77955862787 10.1089/ars.2010.3251
50. Jing E., Emanuelli B., Hirschey M. D., Boucher J., Lee K. Y., Lombard D., Verdin E. M., Kahn C. R., Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proceedings of the National Academy of Sciences of the United States of America 2011 108 35 14608 14613 2-s2.0-80052291180 10.1073/pnas.1111308108
51. Choudhary C., Kumar C., Gnad F., Nielsen M. L., Rehman M., Walther T. C., Olsen J. V., Mann M., Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009 325 5942 834 840 2-s2.0-68949212379 10.1126/science.1175371
52. Parmigiani R. B., Xu W. S., Venta-Perez G., Erdjument-Bromage H., Yaneva M., Tempst P., Marks P. A., HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. Proceedings of the National Academy of Sciences of the United States of America 2008 105 28 9633 9638 2-s2.0-47749156827 10.1073/pnas.0803749105
53. Seo J. H., Lim J. C., Lee D.-Y., Kim K. S., Piszczek G., Nam H. W., Kim Y. S., Ahn T., Yun C.-H., Kim K., Chock P. B., Chae H. Z., Novel protective mechanism against irreversible hyperoxidation of peroxiredoxin: N α -terminal acetylation of human peroxiredoxin II. The Journal of Biological Chemistry 2009 284 20 13455 13465 2-s2.0-67649391256 10.1074/jbc.M900641200
54. Newmeyer D. D., Ferguson-Miller S., Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003 112 4 481 490 2-s2.0-0037459081 10.1016/S0092-8674(03)00116-8
55. Fuchs Y., Steller H., Programmed cell death in animal development and disease. Cell 2011 147 4 742 758 2-s2.0-81055125652 10.1016/j.cell.2011.10.033
56. Jiang X., Wang X., Cytochrome C-mediated apoptosis. Annual Review of Biochemistry 2004 73 87 106 2-s2.0-3943071150 10.1146/annurev.biochem.73.011303. 073706
57. Tait S. W. G., Green D. R., Mitochondria and cell death: outer membrane permeabilization and beyond. Nature Reviews Molecular Cell Biology 2010 11 9 621 632 2-s2.0-77956095537 10.1038/nrm2952
58. Hampton M. B., Stamenkovic I., Winterbourn C. C., Interaction with substrate sensitises caspase-3 to inactivation by hydrogen peroxide. FEBS Letters 2002 517 1-3 229 232 2-s2.0-0037165630 10.1016/S0014-5793(02)02629-7
59. Baker A., Santos B. D., Powis G., Redox control of caspase-3 activity by thioredoxin and other reduced proteins. Biochemical and Biophysical Research Communications 2000 268 1 78 81 2-s2.0-0343340396 10.1006/bbrc.1999.1908
60. Mannick J. B., Hausladen A., Liu L., Hess D. T., Zeng M., Miao Q. X., Kane L. S., Gow A. J., Stamler J. S., Fas-induced caspase denitrosylation. Science 1999 284 5414 651 654 2-s2.0-0033597449 10.1126/science.284.5414.651
61. Galluzzi L., Kroemer G., Necroptosis: a specialized pathway of programmed necrosis. Cell 2008 135 7 1161 1163 2-s2.0-57649167477 10.1016/j.cell.2008.12. 004
62. Vercammen D., Brouckaert G., Denecker G., Van De Craen M., Declercq W., Fiers W., Vandenabeele P., Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. The Journal of Experimental Medicine 1998 188 5 919 930 2-s2.0-0032494143 10.1084/jem.188.5.919
63. Laster S. M., Wood J. G., Gooding L. R., Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. The Journal of Immunology 1988 141 8 2629 2634 2-s2.0-0023697978
64. Vercammen D., Beyaert R., Denecker G., Goossens V., van Loo G., Declercq W., Grooten J., Fiers W., Vandenabeele P., Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. The Journal of Experimental Medicine 1998 187 9 1477 1485 2-s2.0-0032482169 10.1084/jem.187.9.1477
65. Chan F. K.-M., Shisler J., Bixby J. G., Felices M., Zheng L., Appel M., Orenstein J., Moss B., Lenardo M. J., A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. The Journal of Biological Chemistry 2003 278 51 51613 51621 2-s2.0-0347065342 10.1074/jbc.M305633200
66. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.-L., Schneider P., Seed B., Tschopp J., Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunology 2000 1 6 489 495 2-s2.0-5944233768 10.1038/82732
67. Lin Y., Choksi S., Shen H.-M., Yang Q.-F., Hur G. M., Kim Y. S., Tran J. H., Nedospasov S. A., Liu Z.-G., Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. The Journal of Biological Chemistry 2004 279 11 10822 10828 2-s2.0-1642299768 10.1074/jbc.M313141200
68. Kim Y.-S., Morgan M. J., Choksi S., Liu Z.-G., TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Molecular Cell 2007 26 5 675 687 2-s2.0-34249820757 10.1016/j.molcel.2007.04.021
69. He S., Wang L., Miao L., Wang T., Du F., Zhao L., Wang X., Receptor interacting protein kinase-3 determines cellular necrotic response to TNF- α Cell 2009 137 6 1100 1111 2-s2.0-66749183275 10.1016/j.cell.2009.05.021
70. Cho Y., Challa S., Moquin D., Genga R., Ray T. D., Guildford M., Chan F. K.-M., Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009 137 6 1112 1123 2-s2.0-66449133280 10.1016/j.cell.2009.05.037
71. Zhang D.-W., Shao J., Lin J., Zhang N., Lu B.-J., Lin S.-C., Dong M.-Q., Han J., RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009 325 5938 332 336 2-s2.0-67650812332 10.1126/science.1172308
72. Kim Y.-J., Lee W.-S., Ip C., Chae H.-Z., Park E.-M., Park Y.-M., Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. Cancer Research 2006 66 14 7136 7142 2-s2.0-33746878405 10.1158/0008-5472.CAN-05-4446
73. Lee Y. M., Park S. H., Shin D.-I., Hwang J.-Y., Park B., Park Y.-J., Lee T. H., Chae H. Z., Jin B. K., Oh T. H., Oh Y. J., Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. The Journal of Biological Chemistry 2008 283 15 9986 9998 2-s2.0-44349148784 10.1074/jbc.M800426200
74. Song I.-S., Kim S.-U., Oh N.-S., Kim J., Yu D.-Y., Huang S. M., Kim J.-M., Lee D.-S., Kim N.-S., Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Carcinogenesis 2009 30 7 1106 1114 2-s2.0-67650162495 10.1093/carcin/bgp104
75. Jarvis R. M., Hughes S. M., Ledgerwood E. C., Peroxiredoxin 1 functions as a signal peroxidase to receive, transduce, and transmit peroxide signals in mammalian cells. Free Radical Biology and Medicine 2012 53 7 1522 1530 10.1016/j.freeradbiomed.2012.08.001
76. Lee J. Y., Jung H. J., Song I. S., Williams M. S., Choi C., Rhee S. G., Kim J., Kang S. W., Protective role of cytosolic 2-cys peroxiredoxin in the TNF- α -induced apoptotic death of human cancer cells. Free Radical Biology and Medicine 2009 47 8 1162 1171 2-s2.0-70249119939 10.1016/j.freeradbiomed. 2009.07.027
77. Chang T.-S., Cho C.-S., Park S., Yu S., Kang S. W., Rhee S. G., Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. The Journal of Biological Chemistry 2004 279 40 41975 41984 2-s2.0-4744373181 10.1074/jbc.M407707200
78. Cox A. G., Pullar J. M., Hughes G., Ledgerwood E. C., Hampton M. B., Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor-mediated apoptosis. Free Radical Biology and Medicine 2008 44 6 1001 1009 2-s2.0-39949083765 10.1016/j.freeradbiomed.2007.11.017
79. Chae H. Z., Kim H. J., Kang S. W., Rhee S. G., Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Research and Clinical Practice 1999 45 2-3 101 112 2-s2.0-0001445231 10.1016/S0168-8227(99)00037-6
80. Wen S.-T., van Etten R. A., The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes and Development 1997 11 19 2456 2467 2-s2.0-0030803669 10.1101/gad.11.19.2456
81. Mu Z. M., Yin X. G., Prochownik E. V., PAG, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. The Journal of Biological Chemistry 2002 277 45 43175 43184 2-s2.0-0037044804 10.1074/jbc.M206066200
82. Park S.-Y., Yu X., Ip C., Mohler J. L., Bogner P. N., Park Y.-M., Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation. Cancer Research 2007 67 19 9294 9303 2-s2.0-35148890754 10.1158/0008-5472.CAN-07-0651
83. Chhipa R. R., Lee K.-S., Onate S., Wu Y., Ip C., Prx1 enhances androgen receptor function in prostate cancer cells by increasing receptor affinity to dihydrotestosterone. Molecular Cancer Research 2009 7 9 1543 1552 2-s2.0-70349479241 10.1158/1541-7786.MCR-08-0546
84. Riddell J. R., Bshara W., Moser M. T., Spernyak J. A., Foster B. A., Gollnick S. O., Peroxiredoxin 1 controls prostate cancer growth through toll-like receptor 4-dependent regulation of tumor vasculature. Cancer Research 2011 71 5 1637 1646 2-s2.0-79952231198 10.1158/0008-5472.CAN-10-3674
85. Yan Y., Sabharwal P., Rao M., Sockanathan S., The antioxidant enzyme Prdx1 controls neuronal differentiation by thiol-redox-dependent activation of GDE2. Cell 2009 138 6 1209 1221 2-s2.0-70149096624 10.1016/j.cell.2009.06.042
86. 2 produced during disulphide formation. Journal of Cell Science 2010 123 15 2672 2679 2-s2.0-77955359156 10.1242/jcs.067843
87. 2-activated phospholipase D1. FEBS Journal 2005 272 15 3929 3937 2-s2.0-23644456957 10.1111/j.1742-4658.2005.04809. x
88. Pace P. E., Peskin A. V., Han M. H., Hampton M. B., Winterbourn C. C., Hyperoxidized peroxiredoxin 2 interacts with the protein disulfide-isomerase ERp46. Biochemical Journal 2013 453 3 475 485 10.1042/BJ20130030